Linde plc (LIN) reported $36.24B of revenue for the twelve months ended Sep 30, 2026. That is up 8.2% from the year before. Revenue for fiscal 2025 was $33.99B.

Yes. Linde plc earned $7.01B in net income for the twelve months ended Sep 30, 2026, a net margin of 19.3%.

How much cash and debt does LIN have?

Linde plc reported $3.95B in cash and cash equivalents and $22.06B of debt on its most recent balance sheet in SEC filings.

How fast is LIN revenue growing?

Linde plc's revenue changed +3.0% in fiscal 2025, to $33.99B. Its compound annual growth rate was +4.5% over 5 years.

What is LIN free cash flow?

Linde plc generated $5.08B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $10.71B less capital expenditures.

What is LIN earnings per share?

Diluted earnings per share were $15.07 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did LIN last report financial results?

The latest statements here come from Linde plc's 10-Q filed on Oct 29, 2026, covering the period ended Sep 30, 2026.

Where does this LIN financial data come from?

Quantisnow builds these statements from the structured XBRL data Linde plc files with the SEC. It is provided for information only and is not investment advice.

Financials · LIN

Linde plc (LIN) financials

For the twelve months ended Sep 30, 2026, Linde plc reported $36.24B of revenue and $7.01B of net income.

Revenue, TTM: $36.24B
Revenue growth, YoY: +8.2%
Net income, TTM: $7.01B
Net income growth, YoY: -1.2%
Net margin: 19.3%
Free cash flow, TTM: $5.08B
EPS, diluted, TTM: $15.07
EPS growth, YoY: +0.9%
Cash: $3.95B
Total debt: $22.06B
P/E: 34.05
P/S: 6.58
Market cap: $238.60B

Annual revenue$33.99B

FY2016FY2025

Annual net income$6.90B

FY2016FY2025

Annual free cash flow$5.09B

FY2016FY2025

LIN revenue and earnings growth

LIN revenueQ3 2026$9.40B

Quarter YoY: +9.2%
QoQ: +1.2%
FY YoY: +3.0%
5Y CAGR: +4.5%

LIN revenue was $9.40B in fiscal Q3 2026 (ended Sep 30, 2026), up 9.2% from a year earlier and up 1.2% from the prior quarter. For the full fiscal 2025 it was $33.99B, up 3.0% from fiscal 2024. Compound annual growth was +4.5% over 5 years. It rose in 7 of the last 9 fiscal years. Fiscal 2025 is the highest of the 10 fiscal years on file.

LIN net incomeQ3 2026$1.69B

Quarter YoY: -12.3%
QoQ: -12.2%
FY YoY: +5.1%
5Y CAGR: +22.5%

LIN net income was $1.69B in fiscal Q3 2026 (ended Sep 30, 2026), down 12.3% from a year earlier and down 12.2% from the prior quarter. For the full fiscal 2025 it was $6.90B, up 5.1% from fiscal 2024. Compound annual growth was +22.5% over 5 years. It rose in 7 of the last 9 fiscal years. Fiscal 2025 is the highest of the 10 fiscal years on file.

LIN EPSQ3 2026$3.66

Quarter YoY: -10.5%
QoQ: -11.8%
FY YoY: +7.3%
5Y CAGR: +25.4%

LIN diluted EPS was $3.66 in fiscal Q3 2026 (ended Sep 30, 2026), down 10.5% from a year earlier and down 11.8% from the prior quarter. For the full fiscal 2025 it was $14.61, up 7.3% from fiscal 2024. Compound annual growth was +25.4% over 5 years.

LIN free cash flowQ3 2026$1.78B

Quarter YoY: +6.3%
QoQ: +113.3%
FY YoY: +3.3%
5Y CAGR: +4.8%

LIN free cash flow was $1.78B in fiscal Q3 2026 (ended Sep 30, 2026), up 6.3% from a year earlier and up 113.3% from the prior quarter. For the full fiscal 2025 it was $5.09B, up 3.3% from fiscal 2024. Compound annual growth was +4.8% over 5 years. It rose in 6 of the last 9 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$33.99B	$33.01B	$32.85B	$33.36B	$30.79B	$27.24B	$28.23B	$14.84B	$11.36B	$10.53B
Research and development	$147.00M	$150.00M	$146.00M	$143.00M	$143.00M	$152.00M	$184.00M	$113.00M	$93.00M	$92.00M
Selling, general and admin	$3.43B	$3.34B	$3.29B	$3.11B	$3.19B	$3.19B	$3.46B	$1.63B	$1.21B	$1.15B
Operating income	$8.92B	$8.63B	$8.02B	$5.37B	$4.98B	$3.32B	$2.93B	$5.25B	$2.44B	$2.25B
Interest expense	$255.00M	$256.00M	$200.00M	$63.00M	-	-	-	-	-	-
Pre-tax income	$8.90B	$8.57B	$7.99B	$5.54B	$5.10B	$3.38B	$2.93B	$5.05B	$2.29B	$2.05B
Income tax	$1.99B	$2.00B	$1.81B	$1.43B	$1.26B	$847.00M	$769.00M	$817.00M	$1.03B	$551.00M
Net income	$6.90B	$6.57B	$6.20B	$4.15B	$3.83B	$2.50B	$2.29B	$4.38B	$1.25B	$1.50B
EPS, basic	$14.69	$13.71	$12.70	$8.30	$7.40	$4.75	$4.22	$13.26	$4.36	$5.25
EPS, diluted	$14.61	$13.62	$12.59	$8.23	$7.33	$4.71	$4.19	$13.11	$4.32	$5.21
Diluted shares	472.2M	482.1M	492.3M	504.0M	521.9M	531.2M	545.2M	334.1M	289.1M	287.8M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$5.06B	$4.85B	$4.66B	$5.44B	$2.82B	$3.75B	$2.70B	$4.47B	$617.00M	$524.00M
Receivables	$4.97B	$4.62B	$4.72B	$4.56B	$4.50B	$4.17B	$4.32B	$4.30B	$1.71B	-
Inventory	$2.06B	$1.95B	$2.12B	$1.98B	$1.73B	$1.73B	$1.70B	$1.65B	$614.00M	-
Current assets	$13.32B	$12.95B	$12.62B	$13.05B	$10.16B	$10.92B	$10.35B	$17.27B	$3.29B	-
Goodwill	$27.93B	$25.94B	$26.75B	$25.82B	$27.04B	$28.20B	$27.02B	$26.87B	$3.23B	$3.12B
Total assets	$86.82B	$80.15B	$80.81B	$79.66B	$81.61B	$88.23B	$86.61B	$93.39B	$20.44B	-
Current liabilities	$15.20B	$14.54B	$15.72B	$16.48B	$13.64B	$13.74B	$12.16B	$12.96B	$3.31B	-
Short-term debt	$1.80B	$2.06B	$1.26B	$1.60B	$1.71B	$3.25B	$1.73B	$1.49B	$238.00M	-
Long-term debt	$20.68B	$15.34B	$13.40B	$12.20B	$11.34B	$12.15B	$10.69B	$12.29B	$7.78B	-
Total debt	$22.48B	$17.40B	$14.66B	$13.80B	$13.04B	$15.40B	$12.43B	$13.77B	$8.02B	-
Total liabilities	$47.08B	$40.66B	$39.72B	$38.27B	$36.16B	$38.65B	$34.98B	$36.29B	$13.91B	-
Shareholders' equity	$38.24B	$39.48B	$41.08B	$41.37B	$45.43B	$49.57B	$51.52B	$57.08B	$6.51B	$5.44B

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$10.35B	$9.42B	$9.30B	$8.86B	$9.72B	$7.43B	$6.12B	$3.65B	$3.04B	$2.79B
Capital expenditures	$5.26B	$4.50B	$3.79B	$3.17B	$3.09B	$3.40B	$3.68B	$1.88B	$1.31B	$1.47B
Free cash flow	$5.09B	$4.93B	$5.52B	$5.69B	$6.64B	$4.03B	$2.44B	$1.77B	$1.73B	$1.32B
Investing cash flow	-$5.72B	-$4.64B	-$4.67B	-$3.09B	-$3.01B	-$2.99B	$1.19B	$5.36B	-$1.31B	-$1.77B
Financing cash flow	-$4.55B	-$4.36B	-$5.40B	-$3.09B	-$7.59B	-$3.35B	-$9.00B	-$5.00B	-$1.66B	-$659.00M
Dividends paid	$2.81B	$2.65B	$2.48B	$2.34B	$2.19B	$2.03B	$1.89B	$1.17B	$901.00M	$856.00M
Share repurchases	$4.60B	$4.48B	$3.96B	$5.17B	$4.61B	$2.46B	$2.66B	$599.00M	$12.00M	$228.00M
Stock-based compensation	-	-	-	$107.00M	$128.00M	$133.00M	$95.00M	$62.00M	$59.00M	$39.00M
Depreciation and amortization	$3.76B	$3.78B	$3.82B	$4.20B	$4.63B	$4.63B	$4.67B	$1.83B	$1.18B	$1.12B

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	3.0%	0.5%	-1.5%	8.3%	13.0%	-3.5%	90.3%	30.6%	7.8%	-
Net income growth, YoY	5.1%	5.9%	49.5%	8.4%	53.0%	9.5%	-47.8%	251.3%	-16.9%	-
EPS growth, YoY	7.3%	8.2%	53.0%	12.3%	55.6%	12.4%	-	203.5%	-17.1%	-
Operating margin	26.3%	26.2%	24.4%	16.1%	16.2%	12.2%	10.4%	35.4%	21.5%	21.3%
Net margin	20.3%	19.9%	18.9%	12.4%	12.4%	9.2%	8.1%	29.5%	11.0%	14.2%
Free cash flow margin	15.0%	14.9%	16.8%	17.1%	21.6%	14.8%	8.6%	11.9%	15.2%	12.6%
Return on equity	18.0%	16.6%	15.1%	10.0%	8.4%	5.0%	4.4%	7.7%	19.2%	27.6%
Return on assets	7.9%	8.2%	7.7%	5.2%	4.7%	2.8%	2.6%	4.7%	6.1%	-
Current ratio	0.88	0.89	0.80	0.79	0.74	0.80	0.85	1.33	0.99	-
Debt to equity	0.59	0.44	0.36	0.33	0.29	0.31	0.24	0.24	1.23	-

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$9.40B	$9.29B	$8.78B	$8.76B	$8.62B	$8.49B	$8.11B	$8.28B	$8.36B	$8.27B	$8.10B	$8.30B
Research and development	$37.00M	$37.00M	$38.00M	$35.00M	$36.00M	$38.00M	$38.00M	$39.00M	$37.00M	$36.00M	$38.00M	$39.00M
Selling, general and admin	$892.00M	$891.00M	$893.00M	$880.00M	$897.00M	$870.00M	$786.00M	$814.00M	$823.00M	$840.00M	$860.00M	$832.00M
Operating income	$2.15B	$2.55B	$2.44B	$2.02B	$2.37B	$2.35B	$2.18B	$2.27B	$2.09B	$2.18B	$2.10B	$2.03B
Interest expense	$71.00M	$61.00M	$62.00M	$64.00M	$64.00M	$67.00M	$60.00M	$53.00M	$68.00M	$70.00M	$65.00M	$71.00M
Pre-tax income	$2.13B	$2.55B	$2.43B	$2.01B	$2.36B	$2.35B	$2.18B	$2.26B	$2.06B	$2.16B	$2.08B	$2.00B
Income tax	$449.00M	$610.00M	$571.00M	$481.00M	$424.00M	$573.00M	$511.00M	$533.00M	$498.00M	$508.00M	$463.00M	$459.00M
Net income	$1.69B	$1.93B	$1.86B	$1.53B	$1.93B	$1.77B	$1.67B	$1.73B	$1.55B	$1.66B	$1.63B	$1.54B
EPS, basic	$3.67	$4.17	$4.00	$3.30	$4.11	$3.75	$3.53	$3.63	$3.24	$3.46	$3.38	$3.19
EPS, diluted	$3.66	$4.15	$3.98	$3.28	$4.09	$3.73	$3.51	$3.61	$3.22	$3.44	$3.35	$3.15
Diluted shares	462.5M	464.5M	466.3M	-	471.5M	473.6M	476.3M	-	480.9M	483.2M	485.6M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$3.95B	$4.90B	$3.96B	$5.06B	$4.51B	$4.79B	$5.29B	$4.85B	$5.19B	$4.63B	$4.85B	$4.66B
Receivables	$5.59B	$5.63B	$5.32B	$4.97B	$5.33B	$5.23B	$4.95B	$4.62B	$4.87B	$5.00B	$5.01B	$4.72B
Inventory	$2.13B	$2.12B	$2.08B	$2.06B	$2.13B	$2.12B	$1.98B	$1.95B	$2.09B	$2.09B	$2.10B	$2.12B
Current assets	$13.42B	$14.18B	$12.75B	$13.32B	$13.33B	$13.63B	$13.60B	$12.95B	$13.46B	$12.84B	$13.10B	$12.62B
Goodwill	$27.90B	$27.93B	$27.88B	$27.93B	$27.83B	$27.81B	$26.51B	$25.94B	$27.11B	$26.36B	$26.29B	$26.75B
Total assets	$88.08B	$88.35B	$86.31B	$86.82B	$85.99B	$86.08B	$82.70B	$80.15B	$82.55B	$80.22B	$80.35B	$80.81B
Current liabilities	$15.64B	$16.13B	$15.39B	$15.20B	$16.19B	$14.71B	$14.48B	$14.54B	$14.05B	$13.50B	$14.39B	$15.72B
Short-term debt	$1.46B	$2.47B	$1.64B	$1.80B	$2.37B	$1.34B	$1.82B	$2.06B	$1.28B	$1.26B	$1.05B	$1.26B
Long-term debt	$20.59B	$20.68B	$19.86B	$20.68B	$18.59B	$19.70B	$17.61B	$15.34B	$17.48B	$16.93B	$15.23B	$13.40B
Total debt	$22.06B	$23.15B	$21.50B	$22.48B	$20.96B	$21.04B	$19.43B	$17.40B	$18.75B	$18.19B	$16.27B	$14.66B
Total liabilities	$47.08B	$47.72B	$46.22B	$47.08B	$45.91B	$46.09B	$43.24B	$40.66B	$41.94B	$40.66B	$40.12B	$39.72B
Shareholders' equity	$39.42B	$40.62B	$40.08B	$38.24B	$40.07B	$39.97B	$39.45B	$39.48B	$40.59B	$39.54B	$40.22B	$41.08B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$3.17B	$2.27B	$2.24B	$3.03B	$2.95B	$2.21B	$2.16B	$2.81B	$2.73B	$1.93B	$1.95B	$2.73B
Capital expenditures	$1.39B	$1.44B	$1.34B	$1.46B	$1.28B	$1.26B	$1.27B	$1.25B	$1.07B	$1.13B	$1.05B	$1.15B
Free cash flow	$1.78B	$833.00M	$898.00M	$1.57B	$1.67B	$954.00M	$891.00M	$1.56B	$1.67B	$796.00M	$906.00M	$1.58B
Investing cash flow	-$1.33B	-$1.66B	-$1.38B	-$1.46B	-$1.43B	-$1.46B	-$1.37B	-$1.38B	-$957.00M	-$1.27B	-$1.04B	-$1.23B
Financing cash flow	-$2.80B	$321.00M	-$1.97B	-$1.02B	-$1.78B	-$1.37B	-$388.00M	-$1.61B	-$1.27B	-$808.00M	-$668.00M	-$780.00M
Dividends paid	$735.00M	$738.00M	$741.00M	$698.00M	$701.00M	$704.00M	$708.00M	$659.00M	$662.00M	$665.00M	$669.00M	$616.00M
Share repurchases	$954.00M	$871.00M	$807.00M	$1.39B	$989.00M	$1.11B	$1.11B	$1.33B	$667.00M	$1.44B	$1.04B	$1.03B
Depreciation and amortization	$965.00M	$963.00M	$951.00M	$950.00M	$961.00M	$942.00M	$910.00M	$913.00M	$960.00M	$958.00M	$949.00M	$949.00M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	9.2%	9.3%	8.2%	5.8%	3.1%	2.8%	0.1%	-0.2%	2.5%	0.8%	-1.1%	5.1%
Net income growth, YoY	-12.3%	9.2%	11.0%	-11.3%	24.5%	6.2%	2.8%	11.8%	-1.0%	5.6%	7.3%	16.2%
EPS growth, YoY	-10.5%	11.3%	13.4%	-9.1%	27.0%	8.4%	4.8%	14.6%	0.9%	7.8%	9.5%	18.9%
Operating margin	22.9%	27.5%	27.8%	23.0%	27.5%	27.7%	26.9%	27.4%	25.0%	26.4%	25.9%	24.4%
Net margin	18.0%	20.8%	21.1%	17.5%	22.4%	20.8%	20.6%	20.8%	18.5%	20.1%	20.1%	18.6%
Free cash flow margin	18.9%	9.0%	10.2%	17.9%	19.4%	11.2%	11.0%	18.8%	19.9%	9.6%	11.2%	19.0%
Current ratio	0.86	0.88	0.83	0.88	0.82	0.93	0.94	0.89	0.96	0.95	0.91	0.80
Debt to equity	0.56	0.57	0.54	0.59	0.52	0.53	0.49	0.44	0.46	0.46	0.40	0.36

Source: XBRL data Linde plc files with the SEC, latest filing dated Oct 29, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

LIN peers

Company	Revenue	Growth	Net income	Net margin	Market cap
LIN	$36.24B	+8.2%	$7.01B	19.3%	$238.60B
APDAir Products and Chemicals Inc.	$12.60B	+4.5%	-$47.30M	-0.4%	$70.38B
DOWDow Inc.	$42.61B	+4.2%	-$897.00M	-2.1%	$24.74B
IFFInternational Flavors & Fragrances Inc.	$9.98B	-4.6%	$290.00M	2.9%	$24.14B
LYBLyondellBasell Industries NV	$31.96B	+3.5%	$1.30B	4.1%	$21.62B
DDDuPont de Nemours Inc.	$7.06B	+3.2%	$301.00M	4.3%	$19.08B
ALBAlbemarle Corporation	$5.91B	+18.3%	$224.18M	3.8%	$10.69B
SOLSSolstice Advanced Materials Inc.	$4.09B	+9.2%	$210.00M	5.1%	$9.36B
WLKWestlake Corporation	$11.29B	-4.0%	-$1.22B	-10.8%	$9.10B

LIN FAQ

8 questions

What is LIN revenue?
Linde plc (LIN) reported $36.24B of revenue for the twelve months ended Sep 30, 2026. That is up 8.2% from the year before. Revenue for fiscal 2025 was $33.99B.
Is LIN profitable?
Yes. Linde plc earned $7.01B in net income for the twelve months ended Sep 30, 2026, a net margin of 19.3%.
How much cash and debt does LIN have?
Linde plc reported $3.95B in cash and cash equivalents and $22.06B of debt on its most recent balance sheet in SEC filings.
How fast is LIN revenue growing?
Linde plc's revenue changed +3.0% in fiscal 2025, to $33.99B. Its compound annual growth rate was +4.5% over 5 years.
What is LIN free cash flow?
Linde plc generated $5.08B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $10.71B less capital expenditures.
What is LIN earnings per share?
Diluted earnings per share were $15.07 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did LIN last report financial results?
The latest statements here come from Linde plc's 10-Q filed on Oct 29, 2026, covering the period ended Sep 30, 2026.
Where does this LIN financial data come from?
Quantisnow builds these statements from the structured XBRL data Linde plc files with the SEC. It is provided for information only and is not investment advice.